SportGait, Inc. DBA NeuroTech Insights

Improving Health with Gait: the 6th Vital Sign

https://wefunder.com/neurotech.insights

Total raised on Wefunder: 0

Total investors: 0

Quick facts

  • 100K+ athletes served, trusted by Health Systems nationwide, including a U.S. top 5
  • Patented gait & cognition platform—proven testing tools 4–7x more accurate than competition
  • Endorsed by ex-NFL stars Jerome Bettis, Luke Kuechly, Merril Hoge & USA Volleyball's Julia Scoles
  • Capital efficient plan, projecting over $50M revenue by 2029 (not guaranteed)
  • $500M+ valuation potential based on growth comps (not guaranteed)
  • Led by high growth CEO, Chris Newton— launched 8 multimillion $ products from ideation
  • Expanding from concussion to large functional health tech market which serves over 2B people

Team profiles

Featured investor profiles

SportGait, Inc. DBA NeuroTech Insights

Improving Health with Gait: the 6th Vital Sign

EARLY BIRD TERMS: $147,600 LEFT

$2,400

of a $50,000 goal
INVESTMENT TERMS
Preferred Stock
 $15M  $13.5M pre-money valuation $0.32 per share
Early Bird Bonus: The first $150K of investments will be at a $13.5M pre-money valuation

Highlights

1
100K+ athletes served, trusted by Health Systems nationwide, including a U.S. top 5
2
Patented gait & cognition platform—proven testing tools 4–7x more accurate than competition
3
Endorsed by ex-NFL stars Jerome Bettis, Luke Kuechly, Merril Hoge & USA Volleyball's Julia Scoles
4
Capital efficient plan, projecting over $50M revenue by 2029 (not guaranteed)

Related company links

Featured Investors

Team


NeuroTech Insight, proud maker of the SportGait mobile app, used by both professionals and amateurs.

One mobile platform. 10 minutes. AI insights that make functional health measurable—for athletes, aging adults, and billions worldwide.

Why It Matters: Everyone wants a stronger body and a sharper brain!

When the brain and body fall out of sync, lives suffer:

  1. An athlete sidelined by concussion or an ACL tear.
  2. An aging parent losing independence after a fall.
  3. A worker struggling to recover from injury.
  4. An everyday person who just wants to enjoy pickleball without setbacks.

Today’s tools miss what matters most—how the brain controls the body through movement, balance, and executive function. Without that, we can’t reliably predict injury, guide recovery, or prevent decline.

That’s why gait (how you walk) is now recognized as the 6th vital sign. By measuring it alongside cognition, which is our innovative and patent protected approach, we can help millions live longer, healthier, more independent lives.

Powered by AI, our Functional Health Decoder turns movement patterns into actionable insights—predicting risk, personalizing recovery, and optimizing performance. It’s a mobile, scientifically validated, plug-and-play platform for clinics, schools, or any smartphone.

  1. Convenient: Mobile gait lab and cognitive assessment on your phone.
  2. Accurate: 4–7x more accurate than other gait and cognitive tools; greater than 90% neurologist-level accuracy when comparing to physician diagnoses patterns.
  3. Repeatable: Consistent results across time and populations.
  4. Efficient: Quick and easy to deploy in clinics, schools, or at home.

How It Works

In just ~10 minutes on any smartphone, NeuroTech delivers a complete picture of brain-body health:

  1. BKG™ Gait Analysis – measures stride, balance, power, and symmetry.
  2. CPT Cognition – quantifies executive function.
  3. Combined Results – reveal how the body moves under cognitive load.
  4. AI Reporting & Tracking – automatically highlights risks, readiness, and progress over time.


Users establish a baseline once and can re-screen as needed to see what’s changing and why. When no baseline is available, results can be compared against our normative database of 80K+ tests across ages 5-84.

Built on our proven concussion care technology, our AI-powered Functional Health Decoder can now provide a holistic view of functional health. Our Q2 2026 plan is to integrate as a plug-in directly into other companies’ apps and systems, allowing us to rapidly scale with minimal infrastructure ramp up.

Our Impact So Far

  1. 100,000+ athletes positively affected across schools, clinics, and pro sports.
  2. Trusted by clinicians nationwide, including a top 5 health systems and other high profile university and private health systems.
  3. Endorsed by NFL greats Luke Kuechly, Merril Hoge, and Jerome Bettis and US Women’s Professional volleyball player Julia Scoles

The Bigger Picture: Wellness at Scale

While concussion was our proving ground, our platform now expands into performance, recovery, wellness, and aging. Together, these markets touch billions worldwide.

The same plug-and-play platform can extend into:

  1. Prevention, Performance & Recovery – helping athletes and everyday people optimize movement, recover faster, and reduce injury.
  2. Wellness & Longevity – measuring mobility and cognition to catch decline early.
  3. MSK & Neurodegenerative Health – assessing conditions like arthritis, Parkinson’s, and Alzheimer’s.

From the playing field to the aging population, we’re unlocking a massive opportunity to measure and improve functional health for all.

For athletes: NeuroTech provides a fast and accurate way to complete a baseline assessment, which measures whether athletes have deficits and areas to improve. Whether recovering from injury or chasing peak performance, our insights help reduce risk, guide recovery, and unlock improvement.

For aging adults: the same technology tracks balance, mobility, and cognitive function, providing early warning for falls, arthritis, Parkinson’s, and Alzheimer’s. NeuroTech helps aging adults extend quality of life by recognizing deficits early to guide interventions to stay active, independent and safe for longer.

Backed by Patents, Proven by Science

NeuroTech holds exclusive rights to four patents on gait analysis as a biomarker, plus a 2023 filing that protects our AI-driven mobile and wearable platform, creating a strong, defensible moat.

Our platform is built on 40+ years of peer-reviewed research and proven clinical validation — explore the full library of publications that back our science here.

What Sets Us Apart

Most tools in brain health, performance, and wellness look at either cognition (via computer tests) or movement (via balance or simple step tracking). NeuroTech is the only platform that accurately combines both and is deployed through a mobile app. Our addition of AI insights provides a holistic view of a person’s overall functional health.

Here’s what makes NeuroTech different:

  1. Patented Gait Analysis - our BioKinetoGraph (BKG): A portable “gait lab” that’s 4–7x more accurate than other balance and gait measures.
  2. World-Renowned Cognitive Assessment: Scientifically validated and 6–7x more accurate than other neurocognitive tests.
  3. AI Functional Health Decoder: Patent-pending algorithms that link gait + cognition to deliver personalized insights into how the brain controls the body.
  4. Plug-and-Play Expansion: Unlike competitors built for one problem (e.g., concussion or fitness only), our platform is built to scale across performance, wellness, MSK, and neurodegenerative health.

In short: competitors work only with pieces of the puzzle. NeuroTech delivers the whole picture — a decoder for how your brain drives your body.

Expanding Brain–Body Health Globally

NeuroTech’s Functional Health Decoder serves overlapping markets that together reach over 2 billion people worldwide:

  1. Concussion Management4.6M cases annually in the U.S., 58M globally. Our proven entry point is already trusted by schools, clinics, and pro sports organizations.
  2. Prevention, Performance & Recovery (PPR)100M in the U.S., 1.5B globally. Broadest market, covering everyday health, aging populations, and recovery from illness or injury.
  3. Musculoskeletal (MSK) Tech10M people in the U.S., 50M globally. A major unmet need for better tools to prevent injuries, track rehab, and optimize mobility.
  4. Performance Tech90M people in the U.S., 400M globally. Includes athletes, personal trainers, PT/OT practices, and consumer wellness markets.

These markets overlap heavily, meaning one platform can serve multiple use cases across sports, healthcare, and consumer wellness.

Concussion was just the beachhead. With our patented, AI-powered platform, NeuroTech is uniquely positioned to expand into performance, wellness, and aging—markets that touch billions of lives.

How We Go from Validation to Scale

We’ve proven traction through direct sales with schools, clinics, and sports organizations. The next stage of growth comes from large-scale licensing deals with Physical Therapy organizations, MSK providers, wellness companies, performance tech, and pharma/med-tech partners. We are in advanced discussions to pilot with a top ten PPR company and finalizing integration discussions with a leading MSK company.

Transition to Licensing

  1. 2025: 100% direct sales (SportGait app + in-clinic portal).
  2. 2026: 95% direct sales, merger integration, and AI Decoder deployment.
  3. 2027–2029: Rapid shift to licensing—over 80% of revenue from licensing by 2029.

Revenue Path

  1. $400K in 2025 → $50M in 2029.
  2. Licensing grows from virtually zero in 2025 to two-thirds of revenue by 2028.
  3. Fixed costs remain modest, enabling scalable growth with minimal infrastructure.

(Projections are not guaranteed)

Impact

  1. 100K+ people helped in 2025 → 7M people helped by 2029.
  2. Positioned for a $500M+ valuation (in 2029) based on user comps and ARR multiples.

(Projections are not guaranteed)

We’ve validated our technology through direct sales—and now scale efficiently by licensing our Functional Health Decoder to the largest players in MSK, performance, and neurodegenerative health.

Experienced Operators, Backed by Industry Experts and World-Class Advisors

Our team includes award-winning leadership, Harvard-trained doctors, world-class AI innovators, and leaders in sports medicine and neuroscience. Advisors and supporters span NFL athletes, academic researchers, and tech entrepreneurs. This unique blend of proven operators, clinical expertise, data science, and market reach positions NeuroTech as the trusted leader in functional health.


Chris Newton, Chief Executive Officer – 30-year track record; launched 8 multimillion-dollar products; co-inventor on 2 patents; growth architect.

Dr. Anthony Volpe, Chief Analytics Officer – Harvard PhD; AI entrepreneur with 9 successful exits; ex-Lenovo analytics chief.

Steve DeVrieze, Chief Business Officer – 25+ years in software development and healthcare commercialization (Accenture, IQVIA); ex-CEO of Heads Together Health

Nicole Alexande, Customer Success Manager - Professional level Clinical Athletic Trainer; Extensive clinical experience with concussion and functional health.

Dr. Kevin Carneiro, Chief Scientific Officer – UNC physician and Director of the UNC Concussion and Spine Clinic.

Dr. Mark Williams, Gait / BKG Innovator - Physician and Emeritus Ward K. Ensminger Distinguished Professor of Geriatric Medicine in the Department of Medicine at the University of Virginia.

Joel Meyer, Director of Sales – 10+ years in concussion testing/management; helped build nationwide concussion care programs.

Crosby Bugenhagen, Director of Operations – 20 years as an athletic trainer; led statewide concussion programs.


Board/Advisors includes:

NFL stars Luke Kuechly & Merril Hoge, and leaders from Duke, Harvard, and other high-profile healthcare and payer organizations.


From Proving Ground to Global Scale—Join Us

We are raising $2 million in this round to fuel the next phase of growth into our global-scale market opportunities.

Every step tells a story. With your investment, we can turn those steps into healthier lives for athletes, families, and communities worldwide.

NeuroTech Insights is poised to redefine health monitoring the way wearables redefined fitness. By harnessing gait as the 6th vital sign, our platform turns movement into measurable insights to protect athletes, empower aging adults, and unlock human performance. The science is proven, the market is massive, and the moment is now.

Overview